Chronic Polyradiculoneuritis
Symptoms, Doctors, Treatments, Advances & More

Chronic Polyradiculoneuritis Overview

Save information for later
Sign Up

Learn About Chronic Polyradiculoneuritis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Chronic Polyradiculoneuritis Local Doctors?
Elite in Chronic Polyradiculoneuritis
Neurology | Neuromusculoskeletal Medicine | Neurosurgery
Elite in Chronic Polyradiculoneuritis
Neurology | Neuromusculoskeletal Medicine | Neurosurgery

Vickie & Jack Farber Institute For Neuroscience - Honickman Center

1101 Chestnut Street, Floor 10, 
Philadelphia, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Marinos Dalakas is a Neurologist and a Neuromusculoskeletal Medicine provider practicing medicine in Philadelphia, Pennsylvania. Dr. Dalakas is rated as an Elite provider by MediFind in the treatment of Chronic Polyradiculoneuritis. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Stiff Person Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, Hereditary Hyperekplexia, Chronic Polyradiculoneuritis, and Laminectomy. Dr. Dalakas is board certified in Neurology. Dr. Dalakas is currently accepting new patients.

Elite in Chronic Polyradiculoneuritis
Elite in Chronic Polyradiculoneuritis

New Jersey Pediatric Neuroscience Institute

385 Prospect Avenue 2nd Floor, 
Hackensack, NJ 
Languages Spoken:
English
Accepting New Patients

Nizar Souayah is a Psychiatrist practicing medicine in Hackensack, New Jersey. Dr. Souayah is rated as an Elite provider by MediFind in the treatment of Chronic Polyradiculoneuritis. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, and Chronic Polyradiculoneuritis. Dr. Souayah is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Chronic Polyradiculoneuritis
Distinguished in Chronic Polyradiculoneuritis

Vanderbilt Medical Group- Teleneurology

1161 21st Ave South, A-0118 Medical Center North, 
Nashville, TN 
Languages Spoken:
English
Offers Telehealth

Christopher Lee is a Neurologist practicing medicine in Nashville, Tennessee. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Chronic Polyradiculoneuritis. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), Guillain-Barre Syndrome, and Gamma Knife Radiosurgery. Dr. Lee is board certified in American Board Of Psychiatry & Neurology.

What are the latest Chronic Polyradiculoneuritis Clinical Trials?
A Phase 3, Randomized, Double-blind, Study Evaluating Efficacy and Safety of Riliprubart Versus Intravenous Immunoglobulin (IVIg) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy

Summary: The purpose of the study is to evaluate efficacy of riliprubart compared to IVIg in adult participants with CIDP who are receiving maintenance treatment with IVIg. The study duration will be for a maximum of 109 weeks including screening, treatment phases, and follow-up.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Double-blind, Randomized, Multi-Center Study Investigating Efficacy and Safety of Two Different Dosages of Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Summary: The current study is being conducted to assess the efficacy and safety of KIg10 (Intravenous Human Immune globulin 10%) at two different dosages as maintenance therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) following 21 weeks of treatment.